Shanti Natarajan-Amé Selected Research

Shanti Natarajan-Amé Research Topics

3	Infections 03/2019 - 04/2002
3	Neoplasms (Cancer) 11/2008 - 04/2002
3	Aspergillosis 11/2008 - 04/2002
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2012 - 01/2012
1	VEXAS syndrome 11/2022
1	Philadelphia Chromosome 01/2020
1	Renal Insufficiency (Renal Failure) 01/2020
1	Polycythemia Vera 03/2019
1	Primary Myelofibrosis (Myelosclerosis) 03/2019
1	Tuberculosis (Tuberculoses) 03/2019
1	Pleural Effusion (Pleural Effusions) 11/2008
1	Mycoses (Diseases, Fungus) 08/2003
1	Colorectal Neoplasms (Colorectal Cancer) 02/2003
1	Thyroid Neoplasms (Thyroid Cancer) 01/2003
1	Papillary Thyroid Cancer 01/2003
1	Neutropenia 04/2002
1	Fever of Unknown Origin 04/2002

1	SteroidsIBA 11/2022
1	Azacitidine (5 Azacytidine)FDA Link 11/2022
1	Dasatinib (BMS 354825)FDA Link 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	ruxolitinibIBA 03/2019
1	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2012
1	Bortezomib (Velcade)FDA Link 07/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012
1	Bevacizumab (Avastin)FDA Link 01/2012
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2008
1	liposomal amphotericin B FDA Link 08/2003
1	Amphotericin B (Amphotericin)FDA LinkGeneric 08/2003
1	Irinotecan (Camptosar)FDA LinkGeneric 02/2003
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2003
1	Fluorouracil (Carac)FDA LinkGeneric 02/2003
1	Cisplatin (Platino)FDA LinkGeneric 01/2003
1	Proteins (Proteins, Gene)FDA Link 01/2003
1	EnzymesIBA 04/2002
1	galactomannanIBA 04/2002
1	ImmunosorbentsIBA 04/2002

2	Therapeutics 11/2008 - 08/2003
1	Salvage Therapy 04/2005
1	Drug Therapy (Chemotherapy) 02/2003
1	Radiotherapy 02/2003
1	Hematopoietic Stem Cell Transplantation 04/2002